Loopbaan van Donald C. Fresne
Eerdere bekende functies van Donald C. Fresne
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Egenix, Inc.
 Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Directeur/Bestuurslid | - | 17-04-2020 |
| Algemeen Directeur | 25-07-2011 | 19-12-2014 | |
| President | 25-07-2011 | 19-12-2014 | |
Epigen, Inc.
 Epigen, Inc. Medical SpecialtiesHealth Technology Epigen, Inc. develops products to monitor, diagnose and treat cancer n a more effective, less expensive and less invasive manner than other products currently available. The company is in the process of completing the development of its in-vitro blood test, a confirmatory test for prostate cancer. This employs the use of the HC Antigen. It was founded on April 24, 1991. | Voorzitter | 05-03-2010 | 23-09-2010 |
| President | 05-03-2010 | 23-09-2010 |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| President | 2 |
| Chairman | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Epigen, Inc.
Epigen, Inc. Medical SpecialtiesHealth Technology Epigen, Inc. develops products to monitor, diagnose and treat cancer n a more effective, less expensive and less invasive manner than other products currently available. The company is in the process of completing the development of its in-vitro blood test, a confirmatory test for prostate cancer. This employs the use of the HC Antigen. It was founded on April 24, 1991. | Health Technology |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Health Technology |
- Beurs
- Insiders
- Donald C. Fresne
- Ervaring
